New Targets of Thyroid Hormone Action
New Targets of Thyroid Hormone Action
批准号:
8630009
负责人:
ANTHONY N HOLLENBERG
金额:
$53.34万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-16 至 2018-07-31
关键词:
Adverse effectsAffectBile fluidBiochemical GeneticsBiological AssayBiological MarkersBody WeightCardiovascular systemCholesterolCholesterol HomeostasisClinicalDNA MethyltransferaseDNA Modification MethylasesDevelopmentDiagnostic testsDiseaseDissectionDoseEnergy MetabolismExcretory functionGene ExpressionGeneticGenetic ModelsGenetic ProgrammingGenomicsGoalsHealthHeartHepaticHormone replacement therapyHumanHyperthyroidismHypothalamic structureHypothyroidismIndividualIntestinesLeadLightLipidsLiverLiver diseasesMalignant NeoplasmsMeasuresMediator of activation proteinMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMethionine Metabolism PathwayModelingMusNeuronsOrganOutcomePathway interactionsPatientsPeripheralPituitary GlandPlasmaPlayProtein MethyltransferasesProteinsRegulationReplacement TherapyRoleRouteSafetySerumSex Hormone-Binding GlobulinSignal TransductionSkeletal systemSteatohepatitisTherapeuticThyroid Hormone ReceptorThyroid HormonesThyrotropinTimeTissuesToxic effectTreatment EfficacyValidationVariantWorkanalogbonecholesterol absorptionfatty acid oxidationhormone analoghormone therapyimprovedin vivoinsightinsulin sensitivityinterestlipid metabolismmetabolomicsmouse modelnon-alcoholic fatty livernovelprogramspublic health relevanceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Thyroid hormone (TH) is a critical regulator of metabolism and body weight in humans. Indeed,
TH has been shown to regulate energy expenditure, lipid levels and insulin sensitivity to
improve metabolic outcome. Because of these beneficial effects, TH or one of its analogs are
potential therapeutics for a wide variety of metabolic disease. However, if excessively dosed
TH has significant side effects especially on the heart and bone. Remarkably, TH action in
humans is determined almost exclusively by the use of the thyrotropin (TSH) assay which
depends only upon TH action at the level of the hypothalamus and pituitary. Thus, there is a
critical need for improved biomarkers that would allow for tailoring of TH therapy to improve
metabolic health and allow for enhanced safety. To begin to accomplish this we have used
metabolomic profiling and mouse genetic models to began to characterize TH sensitive
pathways in vivo. Our preliminary work has identified unique metabolites that are regulated by
TH that serve both as biomarkers and also as mediators of thyroid hormone action. In this
proposal in the first aim we will extend our analysis of the regulation of metabolite profiles by
TH in a tissue-specific and TH receptor specific fashion and extend our analysis into humans
for the first time. In the second Aim we will determine the mechanism by which TH regulates
methionine metabolism which is likely critical to TH ability to control gene expression and
regulate programs such as fatty acid oxidation. In the third Aim we will use novel genetic
mouse models to determine how TH controls cholesterol metabolism gaining further insight
into a key pathway regulated by TH. Together, completion of these Aims will provide for a new
platform for both understanding and defining TH action in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:10874207
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2023
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Signaling and Development in Humans
-
批准号:10801642
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2023
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Hypothalamic regulation by thyroid hormone receptor phosphorylation
-
批准号:10717820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Corepressor regulation of nuclear receptor action
-
批准号:10562608
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2022
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:9902423
-
项目类别:
-
资助金额:$68.27万
-
财政年份:2019
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:10087920
-
项目类别:
-
资助金额:$65.86万
-
财政年份:2019
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:10337213
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2019
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Corepressor regulation of nuclear receptor action
-
批准号:9701510
-
项目类别:
-
资助金额:$66.99万
-
财政年份:2018
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Development in Mice and Humans
-
批准号:9697589
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2018
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Signaling and Development in Humans
-
批准号:10435571
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2015
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Development in Mice and Humans
-
批准号:9035478
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2015
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Signaling and Development in Humans
-
批准号:10298043
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2015
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:8900278
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:9090055
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:8735134
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Defining the thyroid hormone receptor Cistrome in vivo
-
批准号:8299630
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2011
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Defining the thyroid hormone receptor Cistrome in vivo
-
批准号:8114945
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2011
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Negative regulation by thyroid hormone
-
批准号:8009199
-
项目类别:
-
资助金额:$5.09万
-
财政年份:2010
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Negative regulation by thyroid hormone
-
批准号:7585204
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2007
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Negative regulation by thyroid hormone
-
批准号:7247441
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2007
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
海外基金